Morphosys Company Profile

Aggregated data from the web about Morphosys

Company Name	Morphosys
Website	https://www.morphosys.com
Snippet	MorphoSys is a commercial-stage biopharmaceutical company dedicated to the discovery, development, and delivery of innovative cancer medicines.
Type	Public Company
Founded	1992
Revenue	€71.8 million (2019)[1]
Website	www.morphosys.com
Industry	Biotechnology
Products	Immunotherapy
Traded as	FWB: MOR, NASDAQ: MOR
Key people	Dr. Jean-Paul Kress, Chief Executive OfficerJens Holstein, Chief Financial OfficerDr. Malte Peters, Chief Research & Development OfficerDr. Roland Wandeler, Chief Commercial OfficerDr. Marc Cluzel, Chairman of Supervisory Board
Net income	€-103.0 million (2019)[1]
Headquarters	Planegg, Germany
Total assets	€496.4 million (end 2019)[1]
Total equity	€394.7 million (end 2019)[1]
Operating income	€-107.9 million (2019)[1]
Number of employees	426 (end 2019)[1]

Morphosys is part of the Germany company list

Morphosys is part of the Biotechnology company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.